Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263–7. https://doi.org/10.1200/JCO.2011.37.1039.

Article  PubMed  Google Scholar 

Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol. 2012;13:e362–9. https://doi.org/10.1016/S1470-2045(12)70210-3.

Article  PubMed  Google Scholar 

Kobayashi H, Kotake K, Funahashi K, Hase K, Hirata K, Iiai T, et al. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis. J Gastroenterol. 2014;49:646–54. https://doi.org/10.1007/s00535-013-0820-3.

Article  PubMed  Google Scholar 

Ozawa H, Kotake K, Kobayashi H, Kobayashi H, Sugihara K. Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database. Surg Today. 2014;44:1643–50. https://doi.org/10.1007/s00595-013-0735-x.

Article  PubMed  Google Scholar 

Kobayashi H, Enomoto M, Higuchi T, Uetake H, Iida S, Ishikawa T, et al. Validation and clinical use of the Japanese classification of colorectal carcinomatosis: benefit of surgical cytoreduction even without hyperthermic intraperitoneal chemotherapy. Dig Surg. 2010;27:473–80. https://doi.org/10.1159/000320460.

Article  PubMed  Google Scholar 

Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699–705. https://doi.org/10.1002/bjs.8679.

Article  CAS  PubMed  Google Scholar 

van Gestel YR, de Hingh IH, van Herk-Sukel MP, van Erning FN, Beerepoot LV, Wijsman JH, et al. Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol. 2014;38:448–54. https://doi.org/10.1016/j.canep.2014.04.004.

Article  PubMed  Google Scholar 

Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C, et al. Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study. Dis Colon Rectum. 2015;58:743–52. https://doi.org/10.1097/DCR.0000000000000412.

Article  CAS  PubMed  Google Scholar 

Kumar R, Price TJ, Beeke C, Jain K, Patel G, Padbury R, et al. Colorectal cancer survival: an analysis of patients with metastatic disease synchronous and metachronous with the primary tumor. Clin Colorectal Cancer. 2014;13:87–93. https://doi.org/10.1016/j.clcc.2013.11.008.

Article  PubMed  Google Scholar 

Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14:786–94. https://doi.org/10.1245/s10434-006-9215-5.

Article  PubMed  Google Scholar 

Nagata H, Ishihara S, Hata K, Murono K, Kaneko M, Yasuda K, et al. Survival and prognostic factors for metachronous peritoneal metastasis in patients with colon cancer. Ann Surg Oncol. 2017;24:1269–80. https://doi.org/10.1245/s10434-016-5732-z.

Article  PubMed  Google Scholar 

Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. UICC International Union Against Cancer, 7th Edition. New York: Wiley; 2009.

van Oudheusden TR, Razenberg LG, van Gestel YR, Creemers GJ, Lemmens VE, de Hingh IH. Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin. Sci Rep. 2015;5:18632. https://doi.org/10.1038/srep18632.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005;12:65–71. https://doi.org/10.1007/s10434-004-1167-z.

Article  PubMed  Google Scholar 

Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43. https://doi.org/10.1200/JCO.2003.04.187.

Article  PubMed  Google Scholar 

Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284–92. https://doi.org/10.1200/JCO.2004.10.012.

Article  CAS  PubMed  Google Scholar 

Sánchez-Hidalgo, JM, Rodríguez-Ortiz, L, Arjona-Sánchez Á, Rufián-Peña, S, Casado-Adam, Á, Cosano-Álvarez, et al. Colorectal peritoneal metastases: optimal management review. World J. Gastroenterol. 2019, 25, 3484–3502. https://pubmed.ncbi.nlm.nih.gov/31367152/

Bakkers, C, Lurvink RJ, Rijken A, Nienhuijs SW, Kok N.F, Creemers GJ, Verhoef C, et al. Treatment strategies and prognosis of patients with synchronous or metachronous colorectal peritoneal metastases: a population-based study. Ann Surg. Oncol. 2021;28:9073–83. https://pubmed.ncbi.nlm.nih.gov/34076807/

Quénet F, Elias D, Roca L, Goéré D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicenter, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256–266. https://doi.org/10.1016/S1470-2045(20)30599-4.

Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P., Crezee J, Aalbers AGJ, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicenter, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4:761–70. https://doi.org/10.1016/S2468-1253(19)30239-0.

Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer. Colorectal Dis. 2014;16:359–67. https://doi.org/10.1111/codi.12552.

Article  CAS  PubMed  Google Scholar 

Bushati M, Rovers K, Sommariva A, Sugarbaker P, Morris D, Yonemura Y, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol (EJSO). 2018;44:1942–8 https://pubmed.ncbi.nlm.nih.gov/34020808.

Article  CAS  PubMed  Google Scholar 

Abdel-Rahman O. A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery. Int J Colorectal Dis. 2020;35:719–25. https://pubmed.ncbi.nlm.nih.gov/32060606/

Xue L, Hyman NH, Turaga KK, Eng OS. Peritoneal metastases in colorectal cancer: biology and barriers. J Gastrointest Surg. 2020;24:720–727. https://pubmed.ncbi.nlm.nih.gov/31745890/

Bloemendaal AL, Verwaal VJ, van Ruth S, Boot H, Zoetmulder FA. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol. 2005;31:1145–51. https://doi.org/10.1016/j.ejso.2005.06.002.

Article  CAS  PubMed  Google Scholar 

Klaver YL, Leenders BJ, Creemers GJ, Rutten HJ, Verwaal VJ, Lemmens VE, et al. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin. Am J Clin Oncol. 2013;36:157–61. https://doi.org/10.1097/COC.0b013e3182438c55.

Article  CAS  PubMed  Google Scholar 

Ohira G, Miyauchi H, Hayano K, Maruyama M, Imanishi S, Tochigi T, et al. Treatment outcome of resection of disseminated peritoneal metastases from colorectal cancer. In Vivo. 2020;34:1915–20. https://doi.org/10.21873/invivo.11988

Carmignani CP, Ortega-Perez G, Sugarbaker PH. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol. 2004;30:391–8. https://doi.org/10.1016/j.ejso.2004.01.017.

Article  CAS  PubMed  Google Scholar 

Elias D, Liberale G, Vernerey D, Pocard M, Ducreux M, Boige V, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol. 2005;12:900–9. https://doi.org/10.1245/ASO.2005.01.010.

Article  PubMed  Google Scholar 

van Gestel YR, Thomassen I, Lemmens VE, Pruijt JF, van Herk-Sukel MP, Rutten HJ, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol. 2014;40:963–9. https://doi.org/10.1016/j.ejso.2013.10.001.

Article  PubMed  Google Scholar 

Sugarbaker PH, Chang D. Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators. Eur J Surg Oncol. 2022;48:1619–25. https://doi.org/10.1016/j.ejso.2022.02.001.

Article  PubMed  Google Scholar 

Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717–25. https://doi.org/10.1002/ijc.25596.

Article  CAS  PubMed  Google Scholar 

Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–8. https://doi.org/10.1200/JCO.2009.23.9285.

Article  PubMed  Google Scholar 

Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681–5. https://doi.org/10.1200/JCO.2008.19.7160.

Article